WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Connectomics in Psychiatric Classification

Completed

Conditions: Dementia
Dementia Alzheimers
Frontotemporal Dementia
Pick's Disease With Dementia

Interventions: Device: MRI Brain Imaging
Behavioral: Mental Health Assessment and Computerized Cognitive Test

First Posted Date: 2019-05-30

Last Posted Date: 2020-05-19

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT03967535

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis

Phase 4

Active, not recruiting

Conditions: Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis

Interventions: Drug: Cladribine

First Posted Date: 2019-05-24

Last Posted Date: 2025-03-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 47

Registration Number: NCT03963375

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States
🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

and more 2 locations

Comparison of Movement Pattern Training and Manual Therapy for Prearthritic Hip Disorders

Not Applicable

Completed

Conditions: Dysplasia Mild
Prearthritic Hip Disorder
Hip-related Groin Pain
Femoroacetabular Impingement

Interventions: Other: Manual Therapy
Other: Movement Pattern Training

First Posted Date: 2019-05-22

Last Posted Date: 2023-01-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 33

Registration Number: NCT03959319

Locations: 🇺🇸
Program in Physical Therapy, Washington University, Saint Louis, Missouri, United States

Remifentanil in Children With Obstructive Sleep Apnea

Early Phase 1

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Drug: Remifentanil Infusion

First Posted Date: 2019-05-22

Last Posted Date: 2020-03-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT03958396

Lung Cancer Screening Protocol

Not Applicable

Completed

Conditions: Lung Cancer Screening

Interventions: Other: Toolbox for Lung Cancer Screening

First Posted Date: 2019-05-21

Last Posted Date: 2021-04-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 193

Registration Number: NCT03958253

Locations: 🇺🇸
Decatur Memorial Hospital, Decatur, Illinois, United States
🇺🇸
CoxHealth, Springfield, Missouri, United States
🇺🇸
BJC HealthCare, Barnes-Jewish St. Peters Hospital, Saint Peters, Missouri, United States

and more 4 locations

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Phase 1

Terminated

Conditions: Pancreas Cancer
Pancreatic Cancer
Cancer of the Pancreas

Interventions: Biological: Neoantigen Peptide Vaccine
Drug: Poly ICLC
Procedure: Blood for immune monitoring

First Posted Date: 2019-05-20

Last Posted Date: 2024-07-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 12

Registration Number: NCT03956056

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

Phase 1

Active, not recruiting

Conditions: Endometrial Cancer
Cancer of the Endometrium

Interventions: Drug: TSR-042
Radiation: Brachytherapy
Procedure: Endometrial biopsy
Procedure: Blood draw for immune response

First Posted Date: 2019-05-20

Last Posted Date: 2024-08-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT03955978

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

I-Tracking Neurodegeneration in Early Wolfram Syndrome

Completed

Conditions: Wolfram Syndrome

First Posted Date: 2019-05-15

Last Posted Date: 2024-08-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 127

Registration Number: NCT03951298

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Fluorescence Imaging in Hepatobiliary Surgery

Not Applicable

Withdrawn

Conditions: Hepatobiliary Surgery

Interventions: Device: Cancer goggle system

First Posted Date: 2019-05-13

Last Posted Date: 2022-01-24

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT03946761

Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling

Not Applicable

Terminated

Conditions: Dietary Protein

Interventions: Dietary Supplement: Dietary protein shake

First Posted Date: 2019-05-13

Last Posted Date: 2024-10-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 21

Registration Number: NCT03946774

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy